AIC
AMRX icon

Ameritas Investment Company’s Amneal Pharmaceuticals AMRX Stock Holding History

Ameritas Investment Company’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-47
Closed -$316 – 785
2021
Q1 		$316 Buy
+47
New +$260 ﹤0.01% 2217
2019
Q1 		– Sell
-19
Closed – – 973
2018
Q4 		$0 Buy
+19
New +$342 ﹤0.01% 1509

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Ameritas Investment Company's AMRX Position: Q2 2021 in Review

Ameritas Investment Company sold out of Amneal Pharmaceuticals (AMRX) in Q2 2021, closing a stake of 47 shares — an estimated $316 sold.

Ameritas Investment Company first reported a position in AMRX in Q4 2018 and held it in 2 quarters. The position peaked at $316 in Q1 2021. 160 funds tracked by Wall St. Rank hold AMRX as of Q2 2021.

  • Ameritas Investment Company reported no remaining Amneal Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 47 Amneal Pharmaceuticals shares in Q2 2021, an estimated $316.
  • Ameritas Investment Company first reported a position in Amneal Pharmaceuticals in Q4 2018 and held it in 2 quarters.
  • Ameritas Investment Company's Amneal Pharmaceuticals position peaked at $316 in Q1 2021.
  • 160 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.